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Abstract

Waiting for a Liver transplant: A Qualitative Study
By Ayoka Badmus, PhD(c), MSN, RN-BC, NE-BC
May, 2019
Background: Advances in liver transplantation have significantly improved survival
rates, making liver transplantation a viable option for those with End Stage Liver Failure
(ESLF). However, patients diagnosed with ESLF may experience a significant period of
waiting before a liver transplant surgery, due to a limited supply of donor livers.
Empirical evidence is scarce on the experience of patients waiting for a liver
transplantation.
Method: Using a generic qualitative approach, interviews were conducted with a
purposive sample of twelve patients diagnosed with ESLF, actively wait listed for a liver
transplant. Participants were admitted to the liver disease unit of a teaching hospital at the
time of the study. Transcriptions of interviews and field notes were coded with Atlas ti.
V8. Content analysis of the data identified themes and subthemes relevant to the
objective of the study. May, 2019
Objective: The objective of this study was to explore the waiting experience of patients
diagnosed with ESLF and to identify their perceived challenges and needs while waiting
for a liver transplantation.
Results: Personal description of patients’ experience and challenges while waiting for a
liver transplant. Qualitative analysis of the personal descriptions interview data revealed
that patients have an overarching experience of waiting in limbo while waiting for a liver
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transplant. Three themes (Uncertainty during the Waiting Period; Redefinition of Life;
Challenges during the Waiting Period) and five subthemes (Fear and Anxiety; Physical
Symptoms; Financial Worry; Existing versus Living; Support and Faith) emerged from
the analysis of the data.
Conclusion: Healthcare treatment for patients waiting for a liver transplant needs to be
tailored to accommodate patient reported experience and perceived challenges.
Key Words: liver transplant, Experience, qualitative
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Summary of Study

Advances in liver transplantation has significantly improved survival rates to over
90% and 80% at one and five years post liver transplant respectively, making liver
transplantation a viable option for those with End Stage Liver Failure (ESLF). However
patients diagnosed with ESLF may experience a significant period of waiting before a
liver transplant surgery, due to a limited supply of donor livers. Empirical evidence is
scarce on the experience of patients waiting for a liver transplant. An understanding of
the waiting experience is pivotal to designing appropriate patient centered care. There are
currently 13,403 candidates listed for liver transplant in the United States alone (United
Network for Organ Sharing, 2019). Without a liver transplant, the prognosis for these
patients is grim with a life expectancy of approximately two to twelve years, depending
on severity and comorbidities (Walling & Wenger, 2014; D’Amico & Pagliaro, 2006).
The waiting period before a liver transplant can be a difficult period for patients
because of the symptoms of the disease, uncertainty of transplant surgery and surgical
outcomes. ESLF patients have be shown to have a reduced quality of life that is mainly
due to life-threatening complications of a failed liver (Benzing, 2016; Broschewitz et al.,
2017). Liver transplant candidates are also faced with the stress of uncertainty associated
with not knowing when or if they will be transplanted (Martin, Stone, Scott & Brashers,
2010). Therefore an understanding of patients’ experience during the waiting period is
critical to designing and providing patient appropriate care. Hence, a generic qualitative
descriptive approach (Crabtree & Miller, 1999) was used to describe the perspectives of ESLF
patients waiting for a liver transplant. The goals of this dissertation were to 1) explore how

patients diagnosed with ESLF listed for liver transplant surgery construct their experience
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of waiting and uncertainty and 2) describe the perceived challenges and needs of ESLF
patients waiting for a liver transplant surgery.
The dissertation is comprised of two sections, 1) the research proposal which
follows the summary, outlines the specific aims of the study, the significance of the study
and study methods and 2) manuscripts which includes findings, discussion and themes
supported by participant quotations. Appendices A – I contains the supplemental
information that includes study questionnaire and demographics. Approval for the study
was obtained from the University of Texas Health Science center’s Committee for the
Protection of Human Subjects (CPHS) and from the Houston Methodist Hospital
Institutional Review Board. The PI also completed the Collaborative Institutional
Training Initiative (CITI) modules for protection of human subjects. Interviews were
conducted in February and January of 2019 with concurrent analysis of data from a
purposive sample of patients admitted to a large academic hospital that have a diagnosis
of ESLF and are listed for a liver transplant.
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Proposal
Specific Aims
Chronic liver disease is on the rise and has become the 12th leading cause of death
in the United States (Center for Disease and Control, 2017). Which is an indication that
more patients will be diagnosed with End-Stage Liver Failure (ESLF) and listed for liver
transplant. Thus, increasing wait times for liver transplantation. There are currently
13,902 candidates listed for liver transplant in the United States alone (United Network
for Organ Sharing, 2018). Therefore, there is a significant need for transplant health care
providers to be cognizant of the issues affecting the increasing population of ESLF
patients waiting for a liver transplant.
Liver transplantation is the only life-sustaining treatment for ESLF patients
(Walling & Wenger, 2014). Patients diagnosed with ESLF that meet transplant criteria
are placed on the national liver transplant waiting list (Rahimi-Dehkordi et al. 2014).
However, the waiting time for liver transplantation is prolonged due to the limited supply
of donor organs (Bjørk & Nåden, 2008) and associated with significant stress
(Aghahosseini, Nayeri, Shahsavari, & Tosi, 2017). Awaiting liver transplantation is
accompanied with a fear of death and uncertainty, unfortunately for some listed patients,
death precedes the availability of organs (Hansen, Yan & Rosenkranz, 2014). Provision
of appropriate care to ESLF patients listed for liver transplant require an in-depth
understanding of patients' experience during the waiting period.
The waiting period before a liver transplant can be a difficult period for patients
because of the symptoms of the disease, the uncertainty of transplantation surgery and
outcomes. ESLF patients have be shown to have a reduced quality of life that is mainly
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due to the life-threatening complications of the failed liver (Benzing, 2016; Broschewitz
et al., 2017). Understanding the experiences of patients when waiting for a liver
transplant is pivotal to promoting improved quality of life. Liver transplant candidates
are also faced with the stress of uncertainty associated with not knowing when or if they
will be transplanted (Martin, Stone, Scott & Brashers, 2010). Therefore an understanding
of patients’ experience during the waiting period is critical to designing and providing
patient appropriate care.
However a current review of the literature found a dearth of studies that have
explored the patients' perspectives and experiences when awaiting liver transplantation.
The overall objective of this proposed study is to understand and describe the
experiences, perceived challenges and needs of ESLF patients while waiting for a liver
transplant. The rationale for this study is that the identification of issues that are most
important to ESLF patients during the waiting period will advance care in liver
transplantation. Transplant health care providers can apply the knowledge gained from
this proposed study as a guide for the design of unique patient-centered care that will
address issues that are most pertinent to ESLF patients awaiting liver transplant.
The overall objective of this proposed study will be achieved through the following
specific aims:
Specific Aims:


Explore how patients diagnosed with ESLF listed for liver transplant surgery
construct their experience of waiting and uncertainty.



Describe the perceived challenges and needs of ESLF patients waiting for a liver
transplant surgery.
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Research Questions:


How do patients diagnosed with ESLF waiting for a liver transplant surgery
perceive the waiting period before transplant?



What are the perceived issues and challenges encountered by patients diagnosed
with ESLF while waiting for liver transplant surgery?

The study will serve to illuminate the issues faced by ESLF patients and help clinicians to
better understand patients' perceived needs, challenges and experience during the waiting
period before a liver transplant surgery.
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Research Strategy and Approach
Significance
Continual improvements in liver transplantation has led to a viable therapeutic
option for patients with ESLF. The incidence of graft failure at one year has reduced to
9.8% and approximately 80,000 adults in the United States were living with a functioning
transplanted liver in 2016 (Kim, et al 2016). Without a liver transplant, the prognosis for
patients with ESLF is daunting, with life expectancy of approximately two to twelve
years, depending on etiology, severity and comorbidities (D’amico & Pagliaro, 2006;
Walling & Wenger, 2014) However, the demand for donor livers far exceeds the supply,
therefore patients may encounter a significant wait time before liver transplantation
(Brown, Sorrell, McClaren, & Creswell, 2006).
ESLF patients that meet the criteria for liver transplantation are ranked on a liver
transplant waiting list based on risk of wait list death as defined by a national scoring
system, known as the Model for End-Stage Liver Disease (MELD). A scoring system that
was adopted by United Network for Organ Sharing (UNOS) in 2002, to help ensure a fair
sharing of organs and is based on statistical formulas that are scored from 6 (less ill) to 40
(gravely ill) using the following patients medical and laboratory values: Bilirubin, Serum
Creatinine, Serum Sodium, INR and if patient is on dialysis (Hansen, Yan & Rosenkranz,
2014). The amount of time the patient spends on the wait list is dependent on some
factors such as blood type, body size, availability of donor organs and the MELD score,
making it difficult for providers to accurately predict when a patient would be
transplanted. The concept of wait list is not new to organ transplantation, it emerged
when the number of transplant eligible patients began to exceed the supply of organs
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(Findlay et al. 2011), and this mismatch in demand and supply of organs continues today.
There are currently 13,902 candidates on the liver transplant waiting list in the United
States, compared to 10, 636 in 2015 and 11, 340 in 2016 (US Department of Health &
Human Services, 2018), yet literature is limited on the waiting experience of this growing
population.
There are several factors that may influence the patients’ experience of waiting
for a liver transplant and an understanding of these factors is essential to care. The
waiting period before liver transplant surgery has been associated with psychological and
physiological stress that stems from both the disease process and the uncertainty of
transplantation (Martin, Stone, Scott, & Brashers, 2010). Patients with ESLF have to deal
with life-threatening complications and multiple hospital readmissions related to the
disease process. ESLF is marked by physiological changes that triggers physical
symptoms that impact physical and psychological wellbeing (Rakoski & Volk, 2015).
Physical symptoms such as ascites, hepatic encephalopathy, muscle cramps, fatigue,
bodily discomfort, gastrointestinal discomfort and psychological symptoms such as
anxiety and depression (D'Amico et al, 2006).
The debilitating symptoms of liver failure has been shown to reduce quality of life
by impacting patients’ physical and emotional health (Marchesini et al., 2001; Jara et al.,
2014). In a qualitative study, Bjørk & Nåden (2008) found that patients waiting for liver
transplants experience heightened emotions related to life and death and overwhelming
lack of energy. Crone & Wise (1999) described a similar experience in patients waiting
for a heart transplant and rightly characterized the waiting period as a “dance with death"
because patients feel they have to prepare for the possibility of life and death
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simultaneously. The fear of death is not unfounded as some patients do not survive to
transplantation (Baker & McWilliam, 2003). Waitlist mortality is a genuine challenge in
liver transplantation and is correlated with severity of disease and wait list time (Fayek,
Quintini, Chavin, & Marsh, 2016). Mortality is estimated at 17.6 per 100 waitlist years
for MELD score under 35 and 339.8 per 100 waitlist years for patients with MELD score
over 35 (Kim, 2018). Between patients deaths, de-listing due to severity and
unavailability of livers, only about 50% of patients waiting for a liver received a liver
transplantation in 2016 (Trieu, Bilal & Hmoud, 2017).
Despite all the challenges of the waiting period, little follow-up is available for
patients with ESLF and patients seemed resigned to their fate of suffering while waiting
for a liver transplant surgery (Bjørk & Nåden, 2008). In a qualitative study, Pierce (2014)
identified the need for psychological support and enhanced communication between
patients and health care providers as essential factors in the management of patients
waiting for a liver transplant. The successful management of patients during the waiting
period is important for improved well-being, quality of life and successful posttransplant outcomes in transplant patients (Brown, Sorrell, McClaren, & Creswell,
2006).Yet studies are lacking on the waiting period experience of ESLF patients. An
understanding of patients’ needs and experience is useful for designing appropriate
patient care and management.
The majority of literature in liver transplantation are biomedical with focus on
quantifiable aspects of liver transplantation such as physical symptoms, MELD score and
health related quality of life (Caccamo et al., 2001; Pierce, 2014). The aim of this study is
to fill the existing gap in the knowledge of how patients waiting for a liver transplant
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surgery describe their experience, challenges and needs while waiting. The objective of
this study is best achieved by using a qualitative approach. Qualitative studies are useful
when there is a need for patients’ perspectives and a more comprehensive understanding
of an issue (Cresswell, Klassen, Plano clark, & Smith, 2011). An in-depth understanding
of ESLF patients experience, how they integrate living with the uncertainty and the
limitations of liver failure into their daily lives can help improve the care of patients
waiting for a liver transplant.
Being listed on the transplant list is a major source of hope for patients but as time
elapse, hope may gradually become uncertainty (Pierce, 2014). Therefore the theory of
uncertainty in illness will guide this proposed study. Uncertainty, as described by the
theory, is the lack of ability to determine the meaning of events that are related to illness,
an inability to assign values or to accurately predict outcomes because of insufficient
cues (Mishel, 1988). In the case of ESLF patients waiting for a liver transplant, the
uncertainty experienced during the waiting period is associated with not being able to
accurately predict when or if they will be transplanted. ESLF patients waiting for a liver
transplant are faced with the uncertainty of receiving a transplant (Martin, Stone, Scott, &
Brashers, 2010). Uncertainty is an identified source of stress during the waiting period
before a liver transplantation that Pierce, (2014) clearly described as an “emotional
rollercoaster”, with uncertainty being the one “constant in this state of flux”.
Thus, the overall objective of this study is to better understand the experience,
challenges and needs of patients while waiting for a liver transplant, so to establish a
foundation for developing appropriate and targeted support for ESLF patients awaiting
liver transplantation.
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Innovation
Advancement in technology and pharmaceuticals has generated changes in liver
transplantation, influencing the age and severity of disease of listed patients. The number
of listed candidates over 65 years of age has almost doubled from 2004 to 2014, similarly
there has been an increase in patients listed with high MELD scores (Fayek, Quintini,
Chavin, & Marsh, 2016).This study will consider these changes in practice, utilize the
current scope of practice in study. The study will not have a MELD exclusion and will
include adult patients, over 18 years, with no upper age limitation. Also the study will be
guided by the theory of uncertainty. Although uncertainty has been studied in chronic
illness but literature is lacking in the concept of uncertainty and the waiting experience of
ESLF patients waiting for a liver transplant.
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Research Design and Setting
A generic qualitative descriptive approach (Crabtree &Miller, 1999) will be used
to describe the perspectives of ESLF patients waiting for a liver transplantation – how
they perceive the waiting experience, including their perceived challenges and needs
encountered during the waiting period. The method involves simultaneous data collection
and analysis that is flexible and capable of adjusting to new information that may lead to
the refining of research questions (Kahlke, 2014). Qualitative research methods are useful
when there is a need for more comprehensive understanding of an issue (Cresswell,
Klassen, Plano clark, & Smith, 2011). Data collection and analysis will be conducted
over a period of 12 weeks.
Population, Sample. Sampling Procedures
Purposive sampling will be employed to select participants that meet the inclusion
criteria. The participants will be recruited from ESLF patients admitted to an in-patient
liver failure unit at a Texas hospital (Houston Methodist Hospital) with a robust liver
transplant program. Sampling will attempt to be representative of gender and race.
Inclusion criteria: patients diagnosed with end stage liver failure who are already listed
and waiting for a liver transplantation, adult (18 years and older) with the ability to read,
write and speak English. Exclusion criteria: patients currently admitted for Hepatic
Encephalopathy, cognitive disturbances, history of a previous transplant and inability to
read, write or speak English. Approval will be obtained from the University of Texas
Health Science center’s Committee for the Protection of Human Subjects (CPHS) and
from the Houston Methodist Institutional Review Board.
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Following approval, a printed flyer (Appendix D) with details and objectives of
the study will be posted at the nursing station and in the patient lounge on the liver failure
unit. The flyer will include the Private Investigator’s (PI) contact information so that
eligible participants can contact the PI. The nurses at the in-patient liver failure unit will
serve as key informants to notify patients about the study but will not consent or actively
recruit patients. The eligible participants will be provided with printed information about
the study and the PI’s contact information. The PI will also attend a preexisting monthly
liver transplant support meeting that is held at the teaching hospital and hand out flyers
about the study to augment recruitment efforts. The planned sample size for this study is
12 – 20, based on similar studies found in literature and qualitative study sample, but
recruitment will continue until no new concept is emerging from the data (Crabtree &
Miller, 1999; Bjørk & Nåden, 2008; Marshall et al., 2013; Moser & Korstjens, 2018).
Data collection Procedures
Following recruitment of eligible participants that meet the inclusion criteria, the
PI will meet participants on the in-patient unit at which time, a written consent with full
disclosure will be provided to those that agree to participate and an interview time will be
set up. The informed consent to be used for this study is the Houston Methodist informed
consent form for non-interventional research. The consent form include objectives of the
study, participants’ rights to withdraw from study at any time without penalty and
potential risks (Appendix B). Potential locations are the in-patient rooms on the liver
failure unit, for patient privacy and comfort. Data to be collected include demographic
data (Age, gender and race), MELD score, amount of time spent on waiting list and
etiology of liver disease (Appendix F)
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The PI will collect data using a semi-structured interview format. The participants
will be interviewed individually, face-to-face. Participants may be interviewed more than
once to reach saturation of an emerged concept (Marshall et al., 2013). Interviews will
range from 30 minutes to an hour depending on participants comfort. The interview
questions will include both broad and focused questions that will describe the needs,
challenges and waiting experience of ESLF patients (Appendix E). The interview
questions will be discussed with an expert faculty member for adequacy before data
collection. The PI will use a reflexive journal to promote bracketing to prevent
preconceived biases and assumptions regarding the phenomena under study (Crabtree &
Miller, 1999). Data collection will continue until saturation. The interview will be audiorecorded with a digital voice recorder and the recording quality will be tested prior to the
beginning the interviews. The recording is to reduce distractions during the interviews
and also for play back of recorded interviews during transcription and data analysis.
Transcription of the recordings will be the data. The transcription will be done verbatim
by the PI and reviewed by the PI for completion and accuracy.
Data Analysis
Data collection and analysis will be conducted concurrently, whereby analysis
begins with data collection, helping to direct the flow of the subsequent questions
(Crabtree & Miller, 1999; Thorne, 2008). The PI will listen to the recorded interviews,
verify the transcribed data and code the data. The PI will be immersed in the data, with
the research aim in mind to identify overarching themes and meaningful thinking units
for organization (Crabtree & Miller, 1999). A code book will be created for coding the
data. Thematic content analysis that involves an iterative process of data reduction and
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organizations into categories will be used to construct themes that describe participants’
experience of waiting for a liver transplantation. Insightful quotes from the interviews
will be used to support themes (Thorne, 2008). The PI and a faculty member will review
the data and discuss emerging concepts until consensus. A computer-assisted qualitative
data analysis software (ATLAS.ti 8) will be used to organize and manage the data in a
systematic format.
The study findings will be disseminated by publication in a peer-reviewed journal
at the conclusion of the study. The publication will include direct quotes from
participants and study methods will be substantially described to give readers a sense of
study rigor. Trustworthiness and rigor will be ensured using Lincoln and Guba’s criteria
of credibility, transferability, dependability and confirmability (Cobb & Forbes, 2002).
Peer debriefing will be done with a faculty member that has expertise in qualitative study
to ensure credibility. Transferability will be met by providing adequate description of the
study and context. Finally an audit trail will be provided for dependability and
confirmability. The use of a data analysis software (ATLAS.ti 8) will help to maintain an
audit trail. A journal will also be maintained documenting the decisional processes made
during the study (Crabtree & Miller, 1999).
Study Limitations
Potential loss of confidentiality may hinder recruitments. Patients may not want to
participate because of the fear that the information they provide may jeopardize their
listing status. This will be addressed by emphasizing confidentiality during recruitment
and there will be a statement in the consent to address this issue.
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Human Subjects
Approval will be obtained from the University of Texas Health Science center’s
Committee for the Protection of Human Subjects (CPHS) and from the Houston
Methodist Institutional Review Board. The PI completed the Collaborative Institutional
Training Initiative (CITI) modules for protection of human subjects. Participants will be
informed that participation is entirely voluntary; they may exit the study at any time
without providing a reason. Participants will also be informed that their confidentiality
will be maintained by de-identification of transcripts and demographic questionnaires.
Pseudonyms will be used in reporting of data. Subject codes will be assigned during the
interview and used during transcription for confidentiality of participants. All transcripts
will be stored in a password-protected computer and digital recordings will be stored in a
locked cabinet in the PI’s locked office. All original tape recordings and full transcripts
will be destroyed at the completion of the study.
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Abstract

Background: Advances in liver transplantation have significantly improved survival
rates, making liver transplantation a viable option for those with End Stage Liver Failure
(ESLF). However, patients diagnosed with ESLF may experience a significant period of
waiting before a liver transplant surgery, due to a limited supply of donor livers.
Empirical evidence is scarce on the experience of patients waiting for a liver
transplantation.
Objective: The objective of this study was to explore the waiting experience of patients
diagnosed with ESLF and to identify their perceived challenges and needs while waiting
for a liver transplantation.
Method: Using a generic qualitative approach, interviews were conducted with a
purposive sample of twelve patients diagnosed with ESLF, actively wait listed for a liver
transplant. Participants were admitted to the liver disease unit of a teaching hospital at the
time of the study. Transcriptions of interviews and field notes were coded with Atlas ti.
V8. Content analysis of the data identified themes and subthemes relevant to the
objective of the study.
Results: Personal description of patients’ experience and challenges while waiting for a
liver transplant. Qualitative analysis of the personal descriptions interview data revealed
that patients have an overarching experience of waiting in limbo while waiting for a liver
transplant. Three themes (Uncertainty during the Waiting Period; Redefinition of Life;
Challenges during the Waiting Period) and five subthemes (Fear and Anxiety; Physical
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Symptoms; Financial Worry; Existing versus Living; Support and Faith) emerged from
the analysis of the data.
Conclusion: Healthcare treatment for patients waiting for a liver transplant needs to be
tailored to accommodate patient reported experience and perceived challenges.
Key Words: liver transplant, Experience, qualitative
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Liver transplantation is the only life-sustaining treatment for individuals
diagnosed with End Stage Liver Failure (ESLF) (Walling & Wenger, 2014). The
incidence of graft failure at one year has reduced to 9.8% and approximately 80,000
adults in the United States were living with a functioning transplanted liver in 2016 (Kim,
et al., 2016). Thus, the improvement in liver transplantation provides a viable therapeutic
option for patients with ESLF. However, the waiting time for liver transplantation is
prolonged due to the limited supply of donor organs (Bjørk & Nåden, 2008). There are
currently 13,403 candidates listed for liver transplant in the United States alone (United
Network for Organ Sharing, 2019). Without a liver transplant, the prognosis for patients
with ESLF is grim with a life expectancy of approximately two to twelve years,
depending on severity and comorbidities (Walling & Wenger, 2014; D’Amico &
Pagliaro, 2006).
The demand for donor livers far exceeds the supply, therefore patients may
encounter a significant wait time before liver transplantation (Brown, Sorrell, McClaren,
& Creswell, 2006). The waiting period before liver transplant surgery has been associated
with psychological and physiological stress that stems from both the disease process and
the uncertainty of transplantation (Martin, Stone, Scott, & Brashers, 2010). Therefore,
there is a significant need for health care providers to be cognizant of the experience and
challenges of ESLF patients waiting for a liver transplantation.
ESLF patients that meet the criteria for liver transplantation are ranked on a liver
transplant waiting list based on risk of wait list death as defined by a national scoring
system, known as the Model for End-Stage Liver Disease (MELD). The MELD scoring
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system was adopted by United Network for Organ Sharing (UNOS) in 2002, to help
ensure a fair sharing of organs and is based on statistical formulas that are scored from 6
(less ill) to 40 (gravely ill) using the following patients medical and laboratory values:
Bilirubin, Serum Creatinine, Serum Sodium, International Normalized Ratio and if
patient is on dialysis (Hansen, Yan & Rosenkranz, 2014). The amount of time the patient
spends on the wait list is dependent on factors such as blood type, body size, availability
of donor organs and the MELD score, making it difficult for providers to accurately
predict when a patient would be transplanted.
The concept of a wait list is not new to organ transplantation, it emerged when
the number of transplant eligible patients began to exceed the supply of organs (Findlay
et al., 2011), and this mismatch in demand and supply of organs continues today. The
successful management of patients during the waiting period is important for improved
well-being, quality of life and successful post- transplant outcomes (Brown, Sorrell,
McClaren, & Creswell, 2006). Yet studies are lacking on the experience and challenges
of ESLF patients waiting for a liver transplant. An understanding of patients’ challenges
and experience is useful for designing appropriate patient care and management.
Most of the literature in liver transplantation are biomedical with focus on
quantifiable aspects of liver transplantation such as health related quality of life (Pierce,
2014). The aim of this study is to fill the existing gap in the knowledge of how patients
waiting for a liver transplant surgery perceive and describe their experience, challenges
and needs while waiting. The objective of this study is best achieved by using a
qualitative approach. Qualitative research methods are useful when there is a need for
patients’ perspectives and a broader knowledge of an issue (Creswell, Klassen, Plano
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Clark, & Smith, 2011). An in-depth understanding of ESLF patients experience, how they
integrate living with the uncertainty and the limitations of liver failure into their daily
lives can help improve the care of patients waiting for a liver transplant.
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Method
Design
Using a generic qualitative approach (Crabtree &Miller, 1999), interviews were
conducted to understand the perspectives of patients diagnosed with ESLF, listed and
waiting for a liver transplantation. An understanding of how they perceive the waiting
experience, including their perceived challenges and needs were explored.
Setting and Sample
The participants were all adults, ages 41 to 72 diagnosed with ESLF and on the
waiting list for a liver transplant. Inclusion criteria: patients diagnosed with ESLF who
are already listed and waiting for a liver transplantation, adult (18 years and older) with
the ability to read, write and speak English. Exclusion criteria: patients admitted for
Hepatic Encephalopathy, cognitive disturbances, history of a previous organ transplant
and inability to read, write or speak English.
This study was conducted within a 30-bed liver disease and gastroenterology unit,
staffed with a medical team that consists of physicians, nurse practitioners and registered
nurses. The unit is housed in a large academic hospital situated in the United States. The
academic hospital has a robust multi organ transplant program with a substantial
population of pre-liver transplant patients. A purposive sampling of patients listed for
liver transplant was conducted to obtain a representation of patients waiting for a liver
transplant (Green and Thorogood, 2013).
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Data Collection
At the time of the interview, each participant was given a detailed description of
the study and participants’ questions answered before they signed the consents.
Interviews were conducted using a semi-structured interview guide (Appendix E),
developed to explore the experiences, and challenges of ESLF patients waiting for a
transplant. The Interviews took place on the unit where the participants were admitted as
in-patient for various diagnosis related to ESLF. Interviews were conducted in the
participants’ private rooms to foster privacy. The Primary Investigator (PI) with the help
of the nurses, scheduled interviews at the times that was not disruptive to planned
medical treatment and patient care.
The interviews began with open-ended questions asking participants to describe
their experience of waiting for a liver transplant. Interview questions included both broad
and focused questions. Additional questions were added throughout the interviewing
period to investigate emerging themes. Interviews were conducted between January and
February 2019 and each interview took approximately 30 to 40 minutes. All interviews
were taped recorded and transcribed by the PI into a word document for coding. All data
were de-identified following transcription to safe guard participants’ confidentiality.
Participants were recruited and interviews continued until redundancy in thematic content
and saturation was achieved.
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Procedure
Following approval, a printed flyer (Appendix D) with details and objectives of
the study was posted at the nursing station and in the patient lounge on unit. The flyer
included the PI’s contact information for eligible participants to contact the PI. The
nurses on the unit served as key informants, notifying patients about the study. The
nurses also informed the PI when a potential participant was identified. The PI went to
the unit and provided a verbal description of the study to identified participants. Majority
of those informed about the study agreed to participate instantly, while two participants
contacted the PI within a few days agreeing to participate. Interviews were set up with
those that agreed to participate. The PI gave a copy of the consent to the participants to
sign, following a detailed explanation of the consent and after all participants’ questions
were answered.
The PI for the study is well suited to conduct the study, having worked directly
with ESLF patients waiting for a liver transplant and currently working with those that
have been transplanted. The PI has over eleven years of working in pre and post organ
transplant. With eight of those years working with patients waiting for liver transplant.
This professional experience places the PI in a unique position to appreciate the waiting
experience and challenges of individuals anticipating the gift of life that would be
bestowed by a liver transplant.
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Data Analysis
Following the transcription of interviews and verification of accuracy by the PI,
interview transcripts and field notes were uploaded and stored in a qualitative software
program, ATLAS.ti software (ATLAS.ti 7.1 User manual, 2013). The PI spent time to be
immersed in the data for full comprehension through repeated listening to the audiorecordings and reading of the transcripts. Data analysis begins with keeping accurate
records and immersion in the data, to develop a sense of the whole (Thorne, 2008).
Interview data was transcribed and analyzed following each interview. The concurrent
data collection and analysis helped to direct the flow of subsequent interview questions
(Crabtree & Miller, 1999; Thorne, 2008).
The transcripts were analyzed by applying codes to meaningful phrases. Codes
are words or phrases that are assigned to capture the meaning or essence of data (Saldana,
2012). A code book that was started from the analysis of the first transcript was used for
subsequent analysis. The number of codes increased with the progression of analysis, and
as new concepts that were relevant to the aim of the research emerged. Using thematic
analysis, codes were organized to generate themes relevant to the aim of the study and
insightful quotes from the interviews were used to support the themes (Thorne, 2008).
Data was organized, connected and verified in an iterative process to provide an accurate
representation (Caelli, Ray & Mill, 2003; Kahlke, 2014) of the experience and challenges
of study participants.
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Trustworthiness and rigor were ensured using Lincoln and Guba’s criteria of
credibility, transferability, dependability and confirmability (Cobb & Forbes, 2002).
Adequate description of the study and context is provided to meet transferability. An
audit trail was maintained in ATLAS.ti 8 and journaling was done to document the
decisional processes made during the study (Crabtree & Miller, 1999). The analyzed data,
including codes and themes were debriefed with the PI and three research advisors with
qualitative experience, to confirm that findings were congruent and supported by the data.
A debriefing was also done with an academic peer of the PI with beginning experience in
qualitative research.
Ethical consideration
Approval was obtained from the University of Texas Health Science center’s
Committee for the Protection of Human Subjects (CPHS) and from the Houston
Methodist Institutional Review Board (Appendix A). The PI completed the Collaborative
Institutional Training Initiative (CITI) modules for protection of human subjects.
Participants were informed that participation is entirely voluntary, and they may exit the
study at any time without providing a reason. Participants were also informed that their
confidentiality will be maintained by de-identification of transcripts and demographic
questionnaires. Subject codes were assigned during the interview and used during
transcription for confidentiality of participants. All transcripts were stored in a passwordprotected computer and digital recordings stored in a locked cabinet in the PI’s locked
office. All digital recordings and identifying data were destroyed at the conclusion of the
study.
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Findings
Participants
Twelve participants were interviewed representing the general diversity of
patients diagnosed with ESLF waiting for a liver transplant. As shown in Table 1
(Appendix H), majority of the participants identified themselves as Caucasians (83.3%)
and were mostly males (66.6%). Ages of the participants were between 41 to 72 years of
age. The MELD score of the participants at the time of the interviews ranged between 15
and 32. The etiology of liver failure varied but approximately 50% of the participants had
a failed liver due to Non-Alcoholic SteatoHepatitis cirrhosis (NASH). Majority of the
participants had been on the liver transplant wait list for over a year, with wait time
ranging from two months to six years.
Themes
The identified themes and sub themes from the analysis of the data provides
insight into the experience and challenges of ESLF patients waiting for a liver transplant
surgery. Participants’ identified the experience of waiting for a liver transplant as
temporary but an overwhelming experience that influenced all spheres of life. A period
fraught with several uncertainties that is akin to waiting in limbo. An overarching theme
of Waiting in Limbo resonated throughout the three identified themes (Uncertainty
during the Waiting Period; Redefinition of Life; Challenges during the Waiting Period)
and five subthemes (Fear and Anxiety; Physical Symptoms; Financial Worry; Existing
versus Living; Support and Faith) that emerged from the experience of participants
waiting for a liver transplant as shown in Table 2 (Appendix I). All the participants in the
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study expressed a feeling of uncertainty with regards to time of transplant and surgical
outcomes. The participants described how they have been changed by the challenges and
uncertainty of the waiting period. Figure 1 (Appendix G) is a graphic representation of
the interconnectedness of themes. The uncertainty and challenges experienced during the
waiting period were overlapping. Patients redefined their lives to accommodate the
challenges and uncertainty experienced during the waiting period. The overarching theme
of waiting in limbo resonated throughout all through the experience.
Theme 1: Uncertainty during the Waiting Period.
This theme exemplifies that patients waiting for a liver transplant are faced with
several uncertainties. Not knowing when or if they would receive a liver transplant before
death and consequentially, an inability to plan. Study Participants spoke about the stress
of not being able to predict or plan for the transplant or surgical outcome.
Waiting is not easy, very stressful, you worry about everything and it does not help
because you still don’t know what to expect. I have to keep waiting, hoping to make it…
And if the transplant works, then it would all be worth the wait. (P10)
The study Participants described the experience of not knowing when they would be
transplanted after being placed on the waiting list. Although some participants felt a sense
of accomplishment after being placed on the waiting list, the unpredictability of
transplant was of significance during the waiting period. One of the study’s participants
described the waiting experience vividly as, getting to a mountain top and not knowing
where to go next.
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…the best way I know to explain it is kind of you know, you get to the mountain top, you
finally make it there, where do you go from there. You know, you already at the top, I
guess that is the easiest way to explain it to you. (P3)
Patients waiting for a liver transplant are uncertain about when they would receive a
transplant, the wait could be for a few months or several years. Not knowing when an
organ will be available meant that patients waiting for a liver transplant had to be
prepared at all times for surgery recovery or possible death. The participants in the study
expressed how not knowing when a liver would be available influenced their lives and
prevented them from making plans or accomplishing previously made plans.
You never know when you have to go to the hospital for emergency or even for when they
find a liver, you have to almost have a bag packed and ready, it’s like when you are due
for a baby but you don’t know when the baby is coming, you just get ready. (P9)
The unpredictable hospitalizations related to disease exacerbation or worsening
symptoms was also a concern. The frustrations over severe and unexpected exacerbation
of symptoms requiring hospitalization was verbalized by one participant as a hindrance to
normal life
It is not a normal life because you don’t know when you gonna get sick, like now, I still
don’t know why my esophagus or what they call it is bleeding...1 hate to be working
around with my grandkids and this happens, what are they supposed to do, how do know
when to call 911…The last thing I remember was going to the bathroom, seeing all these
blood and then I woke up, am in the ICU. (P7)
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Subtheme 1.1: Fear and Anxiety.
The uncertainty of liver transplantation sparked a sense of anxiety and fear. When
asked to elaborate on their experience of uncertainty about liver transplant, participants
spoke about their fears and anxiety – fear of death, fear of being too sick for transplant,
fear of the outcome and anxiety about the MELD score.
Scary, oh, very scary, a lot of anxiety, you know, I knew I had a bad liver… (P3)
It is the scariest time, I want the transplant, but I also worry about, hmm death, worse
off… like not coming out of surgery. (P11)
People need to be encouraged, people are scared, dying is not easy. If they have
somebody with them or have someone with the same disease, it helps a little bit…The
goal is survival. (P1)
One Participant told of how this fear is not relived by familiarity with surgical procedure,
liver transplant was considered a “big” surgery
…it’s still scary to me, you know, I know what’s coming and I know the risk, you know
and I have been through many operations, you know I was in a car accident, you know, I
went through neck surgery, I went through arm surgery, went through leg surgery, you
know, but this is big. (P3)
All the participants identified how their wait time was dependent on their MELD score,
but several participants expressed additional apprehension about the MELD score. The
MELD score changed with severity of symptoms and although a high MELD score
placed patients higher on the waiting list, it also signified a deterioration in condition.
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My MELD score is gone up, it’s now 28 so am near the top, but my kidney is going bad,
so my MELD score is gone high, they are saying I may need a kidney too, we just need to
find a liver first before it gets late…not ready to die just now. (P10)
Not scared, am anxious, I like to get it done as soon as possible, my MELD score keeps
going up and down and now it’s gone down, and I have to wait a little longer so that is a
bit bothers me. (P4)
I just don’t know if am going to get a liver if the MELD score keeps going down, it was
high before, but I did that procedure that stops me from bleeding, now they tell me it is
going down. But I can go up to the top of the list if it is high… (P11)
Theme 2: Redefinition of Life.
The loss of independence and the inability to assign meaning or predict transplant
timing or outcomes meant having to redefine life. The study participants of the study
expressed that waiting for a liver transplant is significantly life altering. The waiting
period represented a period of helplessness fueled by uncertainty and physical limitations
but quieted by believing in a higher power. One of the participant identified how she
perceived life during the wait from two view- points – vanity and spirituality
From a vanity point, from a just raw woman feeling point, maybe a 1 out of 10…From a
spiritual point maybe a 5 or 6 out of 10. Where I have awareness that no matter how bad
this is, he is still present with me (Do you mean God?) yes, and there is somebody else
going through worse things than this… (P2)
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Subtheme 2.1: Existing versus Living.
Participants voiced how the waiting period impacted their life and spoke
passionately of their emotional struggles and feelings. They related how extensively their
life has changed so much from what it used to be.
I feel like I don’t have a life anymore, am not suicidal even though my mother thinks I
need some pills but no I don’t. But hmmm I feel like I want to live and not just exist, but
right now I feel like am just existing… It is hard when you have been sick and other
people are making your decisions for you. It is hard because you have been working all
your life and now to totally dependent on my parents… I just want to take better care,
take time out for me, I really want my strength back and just my life. (P2)
I have no life because every time I make plans to go with my daughter or someone to go
to the movies or something, I end up in the hospital or am too sick to get out of bed…
This is what I feel, is that once the transplant is done and I get through the recovering
part, that my life will go back, I will go back to being me and going out and doing
different things. (P9)
Not being able to do what I used to do, have to stay closer to home, my doctor
recommended a cruise at the best and to get insurance that can fly me back if I got sick
but then I have to worry about if an organ becomes available. (P5).
Last week when I just wanted to die, I told my kids, tell the grandkids about me but this
week am much better…There was one day last week, I told my kids, guys I love you but I
just can do this anymore, I said am just going to go ahead and ask God to take me, I was
so miserable but its not my call. (P1)
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The changes that patients experience during the wait led them perceive their lives as not
normal, at least not as they knew it. This caused an emotional turmoil that is evident in
the manner they expressed themselves, as they struggled to hold on to the hope of a
successful transplant outcome.
Subtheme 2.2: Support and Faith.
For many of the participants in this study, faith and family support were
imperative to navigating through the perceived vulnerability and challenges of the
waiting period. The intense reliance on God and family support is echoed in the
statements of the participants:
it is hard, I have moments, in my meditation, at least 3 times a week, where I kind of just
think about it and cry out and I say to myself, I can’t stay in it, I can stay stuck in it. So I
tell myself it will get better, and God has a plan. (P2)
I have a sister, but she lives out in …, if you don’t have nobody, then you are all alone
but am not alone, once I have God, am claiming it, Jesus is the way out of things… (P6)
Many of the participants indicated that having a support system was helpful during the
wait
I would hate to go through this by myself. I don’t see how people do. I got a really good
support system, that helps tremendously… the lord is in control, there is a reason for
everything, makes it easier to deal with it. (P1)
I have a good family, we are real close and they support me. (P4)
I have good family and they are very supportive. (P5)
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Theme 3: Challenges during the Waiting Period.
When asked about challenges and issues encountered during the waiting period,
participants expressed that they struggled with the constraints and worries imposed by
physical symptoms and financial burden.
Subtheme 3.1: Physical Symptoms.
Several participants spoke vividly about the constraints and discomfort imposed
by the exacerbation of symptoms. One participant complained mainly about jaundice and
diarrhea, while another spoke about excess body fluid.
…have so many bad symptoms and Jaundice and it was out of control. I still have it but
not as bad as back then, my eyes looked like a gorilla and hmm, the diarrhea and
everything, it was just a lot. (P2)
All this fluid in my legs and tummy makes it difficult to walk, I have to get a tap
(paracentesis) every week, very tiring but I feel more comfortable when they do the tap
(P9)
While the majority of the participants grappled with disruption in sleep. Almost all the
participants expressed a significant lack of energy and physical weakness. The impact of
sleep disruption and weakness echoed in participants’ statements.
I go get my nails done and fall asleep. I do sleep a lot, and I just get so tired, it just wears
your body down and I can’t drive. I have to sleep and cat nap, you can’t have a full night
sleep..., oh oh, I would love to just have a full night sleep. (P5)
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Just my weakness, being able to do stuff that I was able to do before, can’t go out…just
miss being able to get out of bed, walk to the bathroom, am super weak. (P4)
A lot of weakness am tired all the time. I used to carry furniture and I can barely lift a
chair now, I am so tired, I fall asleep if I drive so I can’t drive, I need a driver. (P8)
Not able to spend time with my grandkids, walk around the mall, doing something besides
lying in bed… My wife and I before I got sick, we travelled a lot and have not been able
to do that in a year and a half. (P1)
Subtheme 3.2: Financial Worry.
Participants expressed concerns about their financial limitations that was caused
by either the loss of employment or cost of healthcare services. These concerns were
irrespective of whether or not they had insurance. Even though they had insurance, there
was still a co-pay that became significant considering a loss of employment or multiple
hospital readmissions. One participant expressed a lack of sleep related to financial
worries and another spoke about the cost of healthcare related services.
I don’t sleep, all the time am worried, I worry how am going to make stuff, how to get a
better camper, my living arrangements, where is this money going to come from, I got
ulcer because I worry too much… (P3)
… Everybody needs money, but things get out of control real quick, get stressful, I have
to pay every-time I come here, I pay parking, I pay insurance, I pay a little for the
medications, not a lot but I still have to pay. (P10)
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Other participants stated that their employment had been affected and described the
challenge in trying to maintain employment.
I can’t work, the last time I tried to do some work, I don’t know what happened at work,
and they had to call the ambulance. (P2)
I haven’t work since over a year, it was hard not being able to work but I was so tired, I
could fall at sleep just like that (P5).
The loss of employment and cost of healthcare services makes it tough for patients
waiting for a liver transplant. The additional cost associated with healthcare, such as
parking and other miscellaneous expenses adds up for quickly.
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Discussion
This study aimed to investigate the experience and challenges of patients waiting
for a liver transplant. Three interrelated themes (Uncertainty during the Waiting period;
Redefinition of Life; and Challenges during the Waiting Period) with an overarching
theme (Waiting in Limbo) were identified in the interviews with study participants. The
study is important in understanding the experience of patients waiting for a liver
transplant from the patient’s perspective; as it is best to evaluate disease management
from the perspective of the patients. The findings from this study provide insight into
how ESLF patients experience the waiting after being placed on the liver transplant
waiting list. Some older studies have shown that patients waiting for organ transplant
have unique experiences and struggle with multiple challenges (Brown et al., 2006, Bjork
& Naden, 2008, Wainwright, 1995).
The findings of this study reflects that waiting for a liver transplant is similar to
waiting in limbo. The Oxford dictionary define limbo as “an uncertain period of awaiting
a decision or resolution; an intermediate state or condition” (Oxforddictionaries.com,
2019). In analysis of the interviews and field notes, an overarching theme of waiting in
limbo was noted. The study participants are faced with a day to day uncertainty of not
knowing what to expect – a hospital admission for a liver transplant or a hospital
admission for an episodic exacerbation of liver failure. The participants in this study
perceived the waiting experience as an overwhelming experience that dominated over all
aspects of their lives, whereby daily decisions were impacted by the nebulousness of
waiting and the disease.
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All the participants in this study expressed a feeling of uncertainty, not knowing
what to expect during the waiting period. Participants were uncertain of the time of
transplant, the outcome of the transplant and if they would survive to transplant. In an
older qualitative study of patients’ experience of waiting for a liver transplantation by
Bjørk and Nåden (2008), patients expressed uncertainty related to life and death.
Similarly, Pierce (2013) also found that patients struggled with not knowing the time of
liver transplant and were focused on “waiting for the phone call” – a call to let them
know that a liver is available. Uncertainty has been a finding in patients waiting for organ
transplant, irrespective of the organ. In a recent qualitative study by Burns, Fernandez,
and Stephens (2017), uncertainty was also a major finding in the experience of patients
waiting for a kidney transplant.
Uncertainty has been documented as a notable feature of the illness experience
(Mishel, 1988), thus not surprising that it was a significant finding in ESLF patients
waiting for a transplant. Mishel (1988) defined uncertainty as “the inability to determine
the meaning of illness-related events” and proposed the theory of uncertainty in illness.
The theory explains how individuals evaluate meaning during experiences of acute
illness; a theory that was later expanded to include chronic illness. According to this
theory, uncertainty occurs when the decision maker is unable to assign definite value to
events or is unable to predict outcomes accurately as depicted by the participants of this
study. The unknown timing for a liver transplant and or the onset of a severe symptom
exacerbation meant patients could not make long or even short plans without
contemplating the possibility of ending up in the hospital. For the participants in this
study, time and planning was relative to transplant, whereby participants spoke in-terms
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of life before transplant and after transplant. Brown at al., (2006) also had a similar
finding and designated it “the paradox of time” in a phenomenological study of patients
waiting for a liver transplant.
When participants in this study were asked to elaborate on their experience with
uncertainty, they expressed feelings of fear and anxiety. Fear and Anxiety are
predominant emotions that have been expressed by patients’ waiting for a liver transplant
(Brown et al., 2006, Bjork & Naden, 2008, Wainwright, 1995). The uncertainty about a
potential threat is disruptive to a person’s ability to mitigate the threat, hence results in
anxiety (Grupe & Nitschke, 2013). Although the participants in this study used fear and
anxiety interchangeably. In a simultaneous concept analysis of fear and anxiety by Bay
and Algase (1999) “fear is defined as the result of disruption from a perceived source that
is identified as threatening, while anxiety arises in response to a vague, nonspecific
threat”. Both of which are applicable to patients waiting for a liver transplant from the
perspectives of the participants in this study. The presence of fear and anxiety in patients
waiting for a transplant is not surprising considering the perceived threats that were
expressed. Participants in this study expressed fears, concerns and anxiety regarding
transplant surgery, being too sick for transplant, the outcome of the transplant and
fluctuations in MELD score.
Fear and anxiety are not uncommon to patients listed for a liver transplant.
Aghahosseini, Nayeri, Shahsavari & Tosi (2017) found that fear and anxiety were the
most unpleasant emotional experience among hepatitis patients waiting for a liver
transplant. Bjørk and Nåden (2008) found the fear of death or developing cancer before
transplant were common among patients waiting for liver transplant. Transplant
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clinicians may help improve the waiting experience of patients by using strategies that
reduce uncertainty, which will reduce fear and anxiety. Communication that has been
shown to be effective tool in the management of uncertainty (Brashers, 2001). Nurses and
other transplant healthcare providers can help lessen patients’ uncertainty and anxiety by
maintaining an open channel of communication during the wait.
While Aghahosseini et al (2017) and Bjørk and Nåden, (2008) did not find the
MELD score to be a source of fear or concern for patients, three of the participants in this
study worried about the fluctuations in their MELD score. As expected, all the
participants knew their Meld score and the significance of the score. The MELD score is
an objective system used to rank liver transplant candidates on the transplant waiting list
according to their severity of liver disease and risk of mortality (Wiesner et al., 2003).
Although, patients desired a high MELD score to move up the transplant list, but a high
MELD score also correlates to increased risk of mortality.
As patients waited hopefully to receive a liver, they redefined their life to
accommodate the challenging experience of the waiting period. Patients waiting for
transplant had to accept and negotiate the loss of health, physical limitations, wavering
emotions, uncertainty and the challenges of waiting (Pierce, 2014; Bjørk and Nåden
2008; Brown et al., 2006). For the participants in this study, the waiting period was a time
of helplessness fueled by uncertainty and physical limitations that is only relieved only
by spiritual beliefs and family support. The study by Bjørk and Nåden (2008), and Brown
et al., (2006) also found that patients waiting for a liver transplant experienced significant
life changes during the wait. Pierce (2014) and Bjørk and Nåden (2008) found patients
went through a redefinition of self as they negotiated the disruptions experienced during
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the waiting period. Participants in this study perceived a change in their normal life and
spoke about their loss of independence and emotional turmoil. One of study participant
stated she felt like she did not have a life anymore, feeling that she was merely existing
and not living.
For patients waiting for a liver, transplant having support and faith are sources of
strength to help endure the wait. As identified in this study and liver transplant literature,
patients waiting for a liver transplant face a series of overwhelming emotional challenges
and must rely on their spiritual beliefs and family support during the wait (Pierce 2014;
Bjørk and Nåden, 2008). Participants in this study described how their faith in God and
family support helped them to face the various challenges and emotional turmoil of the
waiting period. They perceived family as a source of strength and hung on to their
spiritual beliefs; trusting God to guide them through the wait. They expressed the
importance of having a good family support and although, they sometimes felt like a
burden to family, there was a sincere appreciation for the support. One participant stated
he didn’t think anyone could go through the waiting experience without a support,
validating the significant value of support.
The physical symptoms of ESLF was a common problem among the participants
in this study. Participants found the physical symptoms of ESLF challenging and
overwhelming. At the time of the interviews, participants of this study spoke of the
distress experienced due to the core symptoms of ESLF as described in liver disease
literature, including physical weakness, fluid overload, jaundice and fatigue. This is
congruent with findings from the study by Bjørk and Nåden (2008), patients expressed
how they experienced a mental distress related to physical limitation and a lack of
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energy. In both this study and that of Bjørk and Nåden (2008), patients described the
feeling of lack of energy and exhaustion that influenced their life. The underlying cause
of liver associated fatigue is not completely understood, it is a common problem that
impacts the quality of life of patients living with all forms of liver disease (Swain, 2006).
Some of the participants in this study also spoke of disruption in their sleep
pattern that may or may not be related to fatigue. Although almost all the participants
described an intense physical weakness and fatigue, there was no distinct pattern among
the participants in relation to sleep. Some of the participants expressed the inability to
have a full night sleep and took cat naps, while others stated they slept a lot.
Financial worry is a common challenge in the waiting period. Participants
expressed concerns about financial constraints due to either the loss of employment or
cost of treatments. A study by Martin, Stone, Scott & Brashers (2010) to identify the
sources of uncertainty across the transplant trajectory found that patients worried about
unclear financial consequences before an organ transplant. Participants in this study
voiced concerns about their financial situations as related to loss of employment and the
cost of healthcare services. This was irrespective of whether they had insurance. They
had concerns with the cost of co-pay, particularly because they were unemployed and
required recurrent healthcare services. Many individuals in the United States experience
difficulty paying medical bills, even when insured particularly with chronic illness
(Pollitz, Cox, Lucia, & Keith, 2014).
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Limitations
The limitations of this study include the exclusion of non-English speaking
patients, limiting the diversity of the study and the enrollment of only patients admitted at
one medical facility. Also missing was the perspectives of non-acutely ill ESLF patients
waiting for liver transplant. Although qualitative study results are not generalizable to the
population, but their findings are useful for developing testable interventions and tools
for the advancement of healthcare (Leung, 2015).
Relevance to Practice and Future Research
This study contributes to liver transplant literature and adds valuable insights
about the experience and challenges of patients waiting for a liver transplant. An
understanding of patient experience is critical to the selection of appropriate treatment
(Fan & Eiser, 2012). The study has significant implication for practice because the
findings may be useful by clinicians to design appropriate patient care pathways that
incorporates patient experience. Future research should include out-patients participant
to confirm that weakness and fatigue was not an exaggerated effect related to admission
diagnosis but a true challenge of the waiting experience. As many of the participants
spoke about weakness and fatigue, there is merit in exploring tools and interventions that
would help patients increase and maximize energy. Since quality of sleep also appeared
to be a significant issue, patients waiting for transplant would benefit from strategies that
improve the quality of sleep. For example, the use of music assisted relaxation has been
shown to promote sleep and it does not require intensive investment or training, therefore
can be used in patients to improve quality of sleep (De Niet, Tiemens, Lendemeijer, &
Hutschemaekers, 2009).
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Conclusion
Patients waiting for a liver transplant may experience a significant amount of time
waiting for a suitable donor liver. In describing the experience and challenges of patients
waiting for a liver transplant, this study confirmed what has been described in liver
transplant literature with additional insights. The waiting period is notably characterized
with uncertainty, fear, anxiety, economic and physical challenges. Transplant clinicians
can use the findings of this study to provide appropriate support and care to ESLF
patients waiting for transplant.
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Study Protocol
Overall objective:
To understand and describe the experiences, challenges and needs of ESLF patients while
waiting for a liver transplant.
Specific Aims:
 Explore how patients diagnosed with ESLF listed for liver transplant surgery
construct their experience of waiting and uncertainty.
 Describe the perceived challenges and needs of ESLF patients waiting for a liver
transplant surgery.
Research Strategy
Research Design and Setting




A generic qualitative descriptive approach (Crabtree &Miller, 1999) will be used
to describe the perspectives of ESLF patients waiting for a liver transplantation.
Simultaneous data collection and analysis that is flexible and capable of adjusting
to new information that may lead to the refining of research questions to pursue
fruitful lines of inquiry (Kahlke, 2014).
Data collection and analysis will be conducted over a period of 12 weeks.

Population and Sample.
 Purposive sampling will be employed to select participants that meet the inclusion
criteria.
Inclusion criteria:
 Adult (18 years and older).
 Patients diagnosed with end stage liver failure.
 Patients that are listed and waiting for a liver transplantation.
 Patients that have the ability to read, write and speak English.
Exclusion criteria:
 Patients currently admitted for Hepatic Encephalopathy.
 Patients with cognitive disturbances.
 Patients with history of a previous transplant.
 Patients that are unable to read, write or speak English.
Sampling Procedures and Recruitment
 Following approval from Houston Methodist Hospital Institutional review Board
and, the University of Texas Health Science center’s Committee for the Protection
of Human Subjects (CPHS), a printed flyer with details and objectives of the
study will be posted at the nursing station and in the patient lounge on the liver
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failure unit. The flyer will include the contact information for eligible and
interested participants to contact the Primary Investigator (PI).
The use of unit nurses will only inform patients of study but will not actively
recruit or consent patients for the study.
The planned sample size for this study is 20 – 25, based on similar studies found
in literature and recruitment will continue until no new concept is emerging from
the data (Moser & Korstjens, 2018; Marshall et al., 2013; Bjørk & Nåden, 2008).

Data collection Procedures
 A written consent with full disclosure will be provided to those that agree to
participate and an interview time will be set up (consent form include objectives
of the study, participants’ rights to withdraw from study at any time without
penalty and potential risks).
 Interview location is the patient rooms on the liver failure unit, for patient privacy
and comfort.
 The participants will be interviewed individually, face-to-face., using a semistructured format
Data to be collected (Appendix B):
 Age
 Gender
 Race
 MELD score
 Amount of time spent on waiting list
 Etiology of liver disease
The interview questions will include both broad and focused questions that will describe
the needs, challenges and waiting experience of ESLF patients (Appendix A).
The interview will be audio-recorded so as to reduce distractions during the interview
and also for play back of recorded interviews during transcription and data analysis.
The transcription will be done verbatim by the PI and reviewed by the PI for completion
and accuracy.
Data Analysis
 Data collection and analysis will be conducted concurrently, whereby analysis
begins with data collection, helping to direct the flow of the subsequent questions.
 The PI will listen to the recorded interviews, verify the transcribed data and code
the data.
 A code book will be created.
 Thematic content analysis will be used to construct themes that describe
participants’ experience of waiting for a liver transplantation.
Note: A computer-assisted qualitative data analysis software (ATLAS.ti 8) will be used so
as to organize and manage the large data in a systematic format.
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Human Subjects
 Subject codes will be assigned during the interview and used during transcription
for confidentiality of participants.
 The document with patient names will not be kept with transcript and audio
recording.
 All transcripts will be stored in a password-protected computer and tape
recordings will be stored in a locked cabinet in the PI’s office.
 All original tape recordings and full transcripts will be destroyed at the
completion of the study.
Study time frame
 Recruitment and data collection will begin in December 2018, following IRB
approval. Data will be analyzed concurrently with data collection to be concluded
by February of 2019.
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Interview Guide

Begin with welcome and gratitude for participation.
Reiterate (study purpose, interview is recorded, no wrong or right answers and
participants may stop at any time for any reason).
Ask if participants have any question before the beginning of the interview.
Interviews will begin with the open ended broad questions. The rest of the interview will
proceeded with PI listening and using probe questions for clarification of concepts.
Questions
Broad Questions:
1. Tell me about your experience of waiting for a liver transplant.
2. How would you describe your life after you were listed for a transplant?
Probe Questions:
3. What is the impact of waiting for a liver transplant on your everyday life?
4. What is it like to wait for a liver transplant?
5. What are your specific challenges during this waiting period?
6. What are your specific needs during this waiting period?
7. Are your healthcare providers meeting your needs? And if not, explain how
healthcare providers can better meet your needs.
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Demographic Information Form
Study ID (First 2-digit of interviewee’s cell phone number and interview date):

How old are you?

What race do you identify yourself as?

Gender:
 Male
 Female

How long have you been waiting on the liver transplant list (Months/Years):

What is your MELD score?

What is the reason for your liver failure?
 Viral Hepatitis
 Alcoholic Cirrhosis
 Non Alcoholic Fatty Liver disease
 Hepatocellular Carcinoma
 Autoimmune
 Other:
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The experience of waiting for a Liver Transplant

Figure 1. The experience of waiting for a Liver Transplant.
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Demographic Table

Table 1
Demographics of study participants
Study

MELD
Age

Race

Gender

Wait time

Participant

Etiology of ESLF
score

1

65

2

48

Caucasian

Male

1.5 years

28

NASH cirrhosis

Female

2 years

18

Autoimmune

African
American
3

41

Caucasian

Male

2 months

16

NASH cirrhosis

4

66

Caucasian

Female

4 months

27

NASH cirrhosis

5

62

Caucasian

Female

1.2 years

22

NASH cirrhosis

6

60

Caucasian

Male

2 years

18

Hepatitis C Virus

7

53

Hispanic

Male

I year

14

Alcoholic Cirrhosis
Hepatitis C Virus

8

63

Caucasian

Male

6 years

22

and Hepatocellular
Carcinoma

9

66

Caucasian

Female

2 years

31

Alcoholic Cirrhosis

10

55

Caucasian

Male

4.4 years

28

Alcoholic Cirrhosis

11

72

Caucasian

Male

1.5 years

32

NASH cirrhosis

12

62

Caucasian

Male

3.6 years

25

NASH cirrhosis
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Themes Table
Table 2
Overarching Theme, Themes and Subthemes
Overarching Theme:
Themes

Waiting in Limbo

Uncertainty during

Redefinition of Life

the Waiting Period
Subthemes



Fear and Anxiety

Challenges during
the Waiting Period



Existing versus



Living


Support and Faith

Physical
Symptoms



Financial Worry
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